We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$664M
AUM Growth
-$538M
(-45%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-72.87%
Top 10 Holdings %
Top 10 Hldgs %
25.32%
Holding
142
New
15
Increased
24
Reduced
58
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Certara
CERT
|
+$11.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$11.4M |
| 3 |
Privia Health
PRVA
|
+$10M |
| 4 |
Definitive Healthcare
DH
|
+$9.98M |
| 5 |
Arrowhead Research
ARWR
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$17.9M |
| 2 |
Arcus Biosciences
RCUS
|
+$17.7M |
| 3 |
ResMed
RMD
|
+$15.8M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$14.5M |
| 5 |
Evolent Health
EVH
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.16% |
| 2 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
51
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.29M | 0.8% |
49,075
-121,650
| -71% | -$13.3M |
|
52
Arcutis Biotherapeutics
ARQT
$3.36B
| $5.05M | 0.76% |
243,736
-515,027
| -68% | -$10.3M |
|
53
NeoGenomics
NEO
$1.96B
| $5.03M | 0.76% |
147,500
+35,000
| +31% | +$1.37M |
|
54
Medtronic
MDT
$109B
| $4.83M | 0.73% |
46,701
+6,500
| +16% | +$753K |
|
55
BridgeBio Pharma
BBIO
$15.7B
| $4.72M | 0.71% |
282,950
-190,000
| -40% | -$8.04M |
|
56
Natera
NTRA
$38.3B
| $4.66M | 0.7% |
49,850
| – | – |
|
57
Maravai LifeSciences
MRVI
$969M
| $4.61M | 0.69% |
+110,000
| New | +$4.46M |
|
58
Moderna
MRNA
$21.8B
| $4.59M | 0.69% |
18,055
+1,450
| +9% | +$424K |
|
|
BTTX
59
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $4.53M | 0.68% |
973,833
+507,633
| +109% | +$4.16M |
|
|
CNVY
60
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $4.39M | 0.66% |
524,973
-1,214,897
| -70% | -$8.92M |
|
|
RPTX
61
DELISTED
Repare Therapeutics
RPTX
| $4.36M | 0.66% |
206,785
-309,700
| -60% | -$7.3M |
|
62
Treace Medical Concepts
TMCI
$280M
| $4.31M | 0.65% |
231,024
-309,998
| -57% | -$6.4M |
|
63
Biogen
BIIB
$30B
| $4.1M | 0.62% |
17,082
-2,350
| -12% | -$604K |
|
|
TRML
64
DELISTED
Tourmaline Bio
TRML
| $3.98M | 0.6% |
26,058
-55,358
| -68% | -$8.19M |
|
65
Merck
MRK
$322B
| $3.85M | 0.58% |
50,250
-25,000
| -33% | -$1.99M |
|
|
LITS
66
Lite Strategy Inc
LITS
$32.8M
| $3.77M | 0.57% |
70,603
+64,154
| +995% | +$3.58M |
|
|
ITOS
67
DELISTED
iTeos Therapeutics
ITOS
| $3.73M | 0.56% |
80,000
-193,700
| -71% | -$6.45M |
|
68
908 Devices
MASS
$329M
| $3.49M | 0.53% |
134,872
+70,622
| +110% | +$2.08M |
|
|
KLRS
69
Kalaris Therapeutics
KLRS
$83.5M
| $3.38M | 0.51% |
11,350
-101
| -0.9% | -$46.9K |
|
|
JBIO
70
Jade Biosciences
JBIO
$1.2B
| $3.33M | 0.5% |
8,079
-1,674
| -17% | -$847K |
|
|
OLK
71
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.11M | 0.47% |
170,804
-317,838
| -65% | -$7.84M |
|
72
Sight Sciences
SGHT
$286M
| $2.99M | 0.45% |
+170,000
| New | +$3.73M |
|
73
Rallybio
RLYB
$84.5M
| $2.87M | 0.43% |
37,653
-28,239
| -43% | -$3.29M |
|
74
DexCom
DXCM
$31.5B
| $2.73M | 0.41% |
20,300
-45,452
| -69% | -$6.53M |
|
75
Amgen
AMGN
$208B
| $2.69M | 0.4% |
11,953
-1,200
| -9% | -$253K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Sectoral Asset Management held 142 positions worth $664M, down 45% from $1.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management withdrew a net $484M in Q4 2021, closing 34 positions and reducing 58 holdings. Its most notable exit was ResMed, an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Certara worth $9.96M.
- Sectoral Asset Management's largest Q4 2021 buy was Certara: 350,438 shares worth $9.96M.
- Sectoral Asset Management added most to Mirati Therapeutics, Inc. Common Stock in Q4 2021, an estimated $11.4M increase.
- Sectoral Asset Management's biggest Q4 2021 reduction was Agilent Technologies, cutting an estimated $17.9M.
- Sectoral Asset Management fully exited ResMed in Q4 2021, selling an estimated $15.8M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $664M portfolio in Q4 2021.
- Sectoral Asset Management opened 15 new positions and closed 34 in Q4 2021.
- Sectoral Asset Management's portfolio value fell 45% quarter-over-quarter to $664M.
Based on Sectoral Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.